1 |
Cairns AG, North KN : Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 79 : 1165-1170, 2008
DOI
|
2 |
Seol HJ, Shin DC, Kim YS, Shim EB, Kim SK, Cho BK, et al. : Computational analysis of hemodynamics using a two-dimensional model in moyamoya disease. J Neurosurg Pediatr 5 : 297-301, 2010
DOI
|
3 |
Chiang CS, Hong JH, Stalder A, Sun JR, Withers HR, McBride WH : Delayed molecular responses to brain irradiation. Int J Radiat Biol 72 : 45-53, 1997
DOI
|
4 |
Ghosh PS, Rothner AD, Emch TM, Friedman NR, Moodley M : Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol 28 : 95-101, 2013
DOI
|
5 |
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. : A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56 : 34-40, 2011
DOI
|
6 |
Sobata E, Ohkuma H, Suzuki S : Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis : a case report. Neurosurgery 22 : 544-549, 1988
DOI
|
7 |
Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, et al. : The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 99 Suppl 2 : S221-S224, 1997
|
8 |
Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K : Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg 31 : 45-48, 1999
DOI
|
9 |
Bajaj A, Li QF, Zheng Q, Pumiglia K : Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis. PLoS One 7 : e49222, 2012
DOI
|
10 |
Berk AT, Saatci AO, Erçal MD, Tunç M, Ergin M : Ocular findings in 55 patients with Down's syndrome. Ophthalmic Genet 17 : 15-19, 1996
DOI
|
11 |
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. : Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors : a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 : 5277-5282, 2006
DOI
|
12 |
Czarkowski M, Hilgertner L, Powałowski T, Radomski D : The stiffness of the common carotid artery in patients with Graves' disease. Int Angiol 21 : 152-157, 2002
|
13 |
Desai SS, Paulino AC, Mai WY, Teh BS : Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 65 : 1222-1227, 2006
DOI
|
14 |
Fajardo LF : The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44 : 13-22, 2005
DOI
|
15 |
Franklyn JA, Boelaert K : Thyrotoxicosis. Lancet 379 : 1155-1166, 2012
DOI
|
16 |
Im SH, Oh CW, Kwon OK, Kim JE, Han DH : Moyamoya disease associated with Graves disease : special considerations regarding clinical significance and management. J Neurosurg 102 : 1013-1017, 2005
DOI
|
17 |
Fulcher T, Griffin M, Crowley S, Firth R, Acheson R, O'Meara N : Diabetic retinopathy in Down's syndrome. Br J Ophthalmol 82 : 407-409, 1998
DOI
|
18 |
Hasle H, Clemmensen IH, Mikkelsen M : Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355 : 165-169, 2000
DOI
|
19 |
Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T : Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64 : 533-537, 1999
DOI
|
20 |
Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M : Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15 : 179-182, 2000
DOI
|
21 |
Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA : Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7 : 353-361, 1994
DOI
|
22 |
Jea A, Smith ER, Robertson R, Scott RM : Moyamoya syndrome associated with Down syndrome : outcome after surgical revascularization. Pediatrics 116 : e694-e701, 2005
DOI
|
23 |
Jeong HC, Kim YJ, Yoon W, Joo SP, Lee SS, Park YW : Moyamoya syndrome associated with systemic lupus erythematosus. Lupus 17 : 679-682, 2008
DOI
|
24 |
Jett K, Friedman JM : Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12 : 1-11, 2010
|
25 |
Kainth DS, Chaudhry SA, Kainth HS, Suri FK, Qureshi AI : Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease. Neurosurgery 72 : 210-215; discussion 215, 2013
DOI
|
26 |
Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ : Moyamoya syndrome associated with neurofibromatosis Type 1 : perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr 11 : 417-425, 2013
DOI
|
27 |
Keene DL, Johnston DL, Grimard L, Michaud J, Vassilyadi M, Ventureyra E : Vascular complications of cranial radiation. Childs Nerv Syst 22 : 547-555, 2006
DOI
|
28 |
Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, et al. : Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease : a prospective study. Stroke 41 : 173-176, 2010
DOI
|
29 |
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. : Pediatric moyamoya disease : an analysis of 410 consecutive cases. Ann Neurol 68 : 92-101, 2010
DOI
|
30 |
Kuroda S, Houkin K : Moyamoya disease : current concepts and future perspectives. Lancet Neurol 7 : 1056-1066, 2008
DOI
|
31 |
Lee HS, Seol HJ, Kong DS, Shin HJ : Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children. J Korean Neurosurg Soc 50 : 535-537, 2011
DOI
|
32 |
Leno C, Mateo I, Cid C, Berciano J, Sedano C : Autoimmunity in Down's syndrome : another possible mechanism of Moyamoya disease. Stroke 29 : 868-869, 1998
DOI
|
33 |
Malav IC, Kothari SS : Renal artery stenosis due to neurofibromatosis. Ann Pediatr Cardiol 2 : 167-169, 2009
DOI
|
34 |
Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. : Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70 (24 Pt 2) : 2357-2363, 2008
DOI
|
35 |
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. : Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78 : 803-810, 2012
DOI
|
36 |
Panegyres PK, Morris JG, O'Neill PJ, Balleine R : Moyamoya-like disease with inflammation. Eur Neurol 33 : 260-263, 1993
DOI
|
37 |
Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA : Cerebrovascular disease in childhood cancer survivors : a Children's Oncology Group Report. Neurology 73 : 1906-1913, 2009
DOI
|
38 |
Norton KK, Xu J, Gutmann DH : Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2 : 13-21, 1995
DOI
|
39 |
Ohba S, Nakagawa T, Murakami H : Concurrent Graves' disease and intracranial arterial stenosis/occlusion : special considerations regarding the state of thyroid function, etiology, and treatment. Neurosurg Rev 34 : 297-304; discussion 304, 2011
DOI
|
40 |
Parsa CF, Almer Z : Supranumerary optic disc vessels may indicate reduced systemic angiogenesis in Down syndrome. Br J Ophthalmol 92 : 432-433, 2008
DOI
|
41 |
Ram G, Chinen J : Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164 : 9-16, 2011
DOI
|
42 |
Rea D, Brandsema JF, Armstrong D, Parkin PC, deVeber G, MacGregor D, et al. : Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124 : e476-e483, 2009
DOI
|
43 |
Rosser TL, Vezina G, Packer RJ : Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64 : 553-555, 2005
DOI
|
44 |
Scott RM, Smith ER : Moyamoya disease and moyamoya syndrome. N Engl J Med 360 : 1226-1237, 2009
DOI
|
45 |
Shanahan P, Hutchinson M, Bohan A, O' Donoghue D, Sheahan K, Owens A : Hemichorea, moya-moya, and ulcerative colitis. Mov Disord 16 : 570-572, 2001
DOI
|
46 |
Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, et al. : Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68 : 932-938, 2007
DOI
|
47 |
Smith ER, Scott RM : Moyamoya : epidemiology, presentation, and diagnosis. Neurosurg Clin N Am 21 : 543-551, 2010
DOI
|
48 |
Suzuki S, Mitsuyama T, Horiba A, Fukushima S, Hashimoto N, Kawamata T : Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus : report of two cases. Clin Neurol Neurosurg 113 : 325-329, 2011
DOI
|
49 |
Tanigawara T, Yamada H, Sakai N, Andoh T, Deguchi K, Iwamura M : Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S225-S228, 1997
|
50 |
Vis JC, Duffels MG, Winter MM, Weijerman ME, Cobben JM, Huisman SA, et al. : Down syndrome : a cardiovascular perspective. J Intellect Disabil Res 53 : 419-425, 2009
DOI
|
51 |
Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL : Neurofibromatosis type 1 revisited. Pediatrics 123 : 124-133, 2009
DOI
|
52 |
Xu J, Ismat FA, Wang T, Yang J, Epstein JA : NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Circulation 116 : 2148-2156, 2007
DOI
|
53 |
Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. : Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31 : 930-935, 2000
DOI
|
54 |
Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG : Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99 Suppl 2 : S58-S60, 1997
|